Adani and Sirius form JV to digitally transform India's digital economy
Sirius JV will be owned 51% by Sirius and 49% by Adani
Sirius JV will be owned 51% by Sirius and 49% by Adani
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
Furthering cell therapy ambition across oncology and autoimmune diseases
Clariant Healthcare highlighted Vitipure Meglumine LEX and VitiPure Superior at the recently concluded CPhI India
Lacosamide is indicated to treat partial-onset seizures
Darunavir is a protease inhibitor antiviral medicine that prevents Human Immunodeficiency Virus (HIV-1) from multiplying in the body
Cyclophosphamide is a chemotherapy medication that slows the growth of cancer cell
Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
The company makes its maiden entry into Azerbaijan’s pharmaceutical market
Leading USA based genetic testing brand officially enters the Indian market
Subscribe To Our Newsletter & Stay Updated